Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Carson

Showing results (731-740 of 918) with videos related to

Pageof 92
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2017
Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanomaMegan C Duggan, Andrew R Stiff, Maryam Bainazar, et al.
Cancer Research|October 17, 2008
IFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosisGregory B Lesinski, Ene T Raig, Kristan Guenterberg, et al.
Brain, Behavior, and Immunity|June 20, 2014
Attachment anxiety is related to Epstein-Barr virus latencyChristopher P Fagundes, Lisa M Jaremka, Ronald Glaser, et al.
Melanoma Research|January 30, 2025
A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockadeColin D Angell, Steven H Sun, Gabriella Lapurga, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 3, 2015
(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areasEunkyung Park, Jean-Dominique Gallezot, Aracely Delgadillo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 22, 2016
Determination of receptor occupancy in the presence of mass dose: [<sup>11</sup>C]GSK189254 PET imaging of histamine H<sub>3</sub> receptor occupancy by PF-03654746Jean-Dominique Gallezot, Beata Planeta, Nabeel Nabulsi, et al.
Iscience|June 5, 2023
CD200R signaling contributes to unfavorable tumor microenvironment through regulating production of chemokines by tumor-associated myeloid cellsCho-Hao Lin, Fatemeh Talebian, Yang Li, et al.
ACS Chemical Neuroscience|January 22, 2020
Synthesis and Preclinical Evaluation of an <sup>18</sup>F-Labeled Synaptic Vesicle Glycoprotein 2A PET Imaging Probe: [<sup>18</sup>F]SynVesT-2Zhengxin Cai, Songye Li, Wenjie Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapyJonathan P Butchar, Payal Mehta, Steven E Justiniano, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
A phase I trial of bortezomib and interferon-α-2b in metastatic melanomaJoseph Markowitz, Eric A Luedke, Valerie P Grignol, et al.
Pageof 92

Showing results (731-740 of 918) with videos related to

Sort By:
Pageof 92
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2017
Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanomaMegan C Duggan, Andrew R Stiff, Maryam Bainazar, et al.
Cancer Research|October 17, 2008
IFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosisGregory B Lesinski, Ene T Raig, Kristan Guenterberg, et al.
Brain, Behavior, and Immunity|June 20, 2014
Attachment anxiety is related to Epstein-Barr virus latencyChristopher P Fagundes, Lisa M Jaremka, Ronald Glaser, et al.
Melanoma Research|January 30, 2025
A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockadeColin D Angell, Steven H Sun, Gabriella Lapurga, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 3, 2015
(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areasEunkyung Park, Jean-Dominique Gallezot, Aracely Delgadillo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 22, 2016
Determination of receptor occupancy in the presence of mass dose: [<sup>11</sup>C]GSK189254 PET imaging of histamine H<sub>3</sub> receptor occupancy by PF-03654746Jean-Dominique Gallezot, Beata Planeta, Nabeel Nabulsi, et al.
Iscience|June 5, 2023
CD200R signaling contributes to unfavorable tumor microenvironment through regulating production of chemokines by tumor-associated myeloid cellsCho-Hao Lin, Fatemeh Talebian, Yang Li, et al.
ACS Chemical Neuroscience|January 22, 2020
Synthesis and Preclinical Evaluation of an <sup>18</sup>F-Labeled Synaptic Vesicle Glycoprotein 2A PET Imaging Probe: [<sup>18</sup>F]SynVesT-2Zhengxin Cai, Songye Li, Wenjie Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapyJonathan P Butchar, Payal Mehta, Steven E Justiniano, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
A phase I trial of bortezomib and interferon-α-2b in metastatic melanomaJoseph Markowitz, Eric A Luedke, Valerie P Grignol, et al.
Pageof 92